loadpatents
name:-0.027427911758423
name:-0.010786056518555
name:-0.0058219432830811
GEISSLINGER; Gerd Patent Filings

GEISSLINGER; Gerd

Patent Applications and Registrations

Patent applications and USPTO patent grants for GEISSLINGER; Gerd.The latest application filed is for "n-terminally truncated interleukin-38".

Company Profile
4.13.26
  • GEISSLINGER; Gerd - Bad Soden DE
  • Geisslinger; Gerd - Frankfurt am Main N/A DE
  • Geisslinger; Gerd - Nuremberg DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
N-terminally Truncated Interleukin-38
App 20200277349 - WEIGERT; Andreas ;   et al.
2020-09-03
Oxidized Lipids As Biomarkers For Neuropathic Pain
App 20200200775 - SISIGNANO; Marco ;   et al.
2020-06-25
N-terminally truncated interleukin-38
Grant 10,618,946 - Weigert , et al.
2020-04-14
Cyp2j2 Antagonists In The Treatment Of Pain
App 20200101055 - SISIGNANO; Marco ;   et al.
2020-04-02
Inhibitors Of Gpr132 For Use In Preventing And/or Treating Chemotherapy-induced Neuropathic Pain
App 20190211397 - SCHIFFMANN; Susanne ;   et al.
2019-07-11
Samhd1 Modulation For Treating Resistance To Cancer Therapy
App 20180313843 - KEPPLER; Oliver Till ;   et al.
2018-11-01
Blt2 Agonists For The Treatment Of Pain
App 20170281575 - SCHOLICH; Klaus ;   et al.
2017-10-05
Cyp2j2 Antagonists In The Treatment Of Pain
App 20170266169 - SISIGNANO; Marco ;   et al.
2017-09-21
N-terminally Truncated Interleukin-38
App 20170218039 - WEIGERT; Andreas ;   et al.
2017-08-03
Use of a granulin or a granulin-like compound for the therapy or prophylaxis of chronic pain
Grant 9,655,947 - Tegeder , et al. May 23, 2
2017-05-23
Non-invasive Method For Prediction Of Opioid-analgesia And Opioid-blood-concentrations
App 20160345895 - LOETSCH; Joern ;   et al.
2016-12-01
Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds
Grant 9,271,992 - Michaelis , et al. March 1, 2
2016-03-01
Inhibitors Of Nox4 Expression And /or Nox4 Function And Their Use In The Prevention And Treatment Of Nerve Injury And/or Neuropathic Pain
App 20150051264 - Schmidtko; Achim ;   et al.
2015-02-19
Use of I.kappa.B-kinase inhibitors in pain therapy
Grant 8,809,358 - Michaelis , et al. August 19, 2
2014-08-19
Novel Treatment of Multiple Sclerosis (MS)
App 20130309199 - Tegeder; Irmgard ;   et al.
2013-11-21
Use Of A Granulin Or A Granulin-like Compound For The Therapy Or Prophylaxis Of Chronic Pain
App 20130102656 - TEGEDER; IRMGARD ;   et al.
2013-04-25
Use of a granulin or a granulin-like compound in the therapy or prophylaxis of chronic pains
Grant 8,367,616 - Tegeder , et al. February 5, 2
2013-02-05
Use of R-arylpropionic acids for treating illnesses with a rheumatic nature
Grant 8,092,829 - Geisslinger , et al. January 10, 2
2012-01-10
Method For Alleviating Pain Using Protein Associated With Myc And Related Compounds, And Assays For Identifying Such Compounds
App 20110105405 - MICHAELIS; Martin ;   et al.
2011-05-05
Use of a Granulin or a Granulin-Like Compound in the Therapy or Prophylaxis of Chronic Pains
App 20100261657 - Tegeder; Irmgard ;   et al.
2010-10-14
Method For Alleviating Pain Using Sphingosine-1-phosphate And Related Compounds, And Assays For Identifying Such Compounds
App 20100137257 - MICHAELIS; Martin ;   et al.
2010-06-03
Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds
Grant 7,691,563 - Michaelis , et al. April 6, 2
2010-04-06
Drugs As Well As Their Production And Use In The Treatment Of Pain-associated Neuropathies
App 20090162421 - GEISSLINGER; Gerd ;   et al.
2009-06-25
2-amino-1,3-propanediol compounds for the treatment of acute pain
Grant 7,524,887 - Michaelis , et al. April 28, 2
2009-04-28
Use of IKappaB-Kinase Inhibitors in Pain Therapy
App 20090069358 - MICHAELIS; Martin ;   et al.
2009-03-12
Use of I.kappa.B-kinase inhibitors in pain therapy
Grant 7,462,638 - Michaelis , et al. December 9, 2
2008-12-09
Use of active ingredients having a mu-opioid receptor agonist action and an opiod receptor antognist action, as combination drugs for the treatment of cancer
App 20050043280 - Geisslinger, Gerd ;   et al.
2005-02-24
Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds
App 20050032744 - Michaelis, Martin ;   et al.
2005-02-10
Method for alleviating pain using protein associated with MYC and related compounds, and assays for identifying such compounds
App 20050032695 - Michaelis, Martin ;   et al.
2005-02-10
Use of calpain for identifying compounds that modulate pain
App 20050014182 - Michaelis, Martin ;   et al.
2005-01-20
2-Amino-1,3-propanediol compounds for the treatment of various types of pain
App 20040248988 - Michaelis, Martin ;   et al.
2004-12-09
Use of IkappaB-kinase inhibitors in pain therapy
App 20040116494 - Michaelis, Martin ;   et al.
2004-06-17
Use or r-arylpropionic acids for producing medicaments for treating illnesses with a rheumatic nature
App 20040037876 - Geisslinger, Gerd ;   et al.
2004-02-26
Medicament and its production and use in the treatment of pain, inflammation and fever in man and animals
Grant 5,200,198 - Geisslinger , et al. April 6, 1
1993-04-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed